These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 33576875)

  • 1. Metabolic profiles of regulatory T cells in the tumour microenvironment.
    Rao D; Verburg F; Renner K; Peeper DS; Lacroix R; Blank CU
    Cancer Immunol Immunother; 2021 Sep; 70(9):2417-2427. PubMed ID: 33576875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges.
    Pacella I; Piconese S
    Front Immunol; 2019; 10():1889. PubMed ID: 31507585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects.
    Li C; Jiang P; Wei S; Xu X; Wang J
    Mol Cancer; 2020 Jul; 19(1):116. PubMed ID: 32680511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treg programming and therapeutic reprogramming in cancer.
    Moreno Ayala MA; Li Z; DuPage M
    Immunology; 2019 Jul; 157(3):198-209. PubMed ID: 30866047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
    Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
    J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remodeling of the tumor microenvironment via disrupting Blimp1
    Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
    Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OX40+ Regulatory T Cells in Cutaneous Squamous Cell Carcinoma Suppress Effector T-Cell Responses and Associate with Metastatic Potential.
    Lai C; August S; Albibas A; Behar R; Cho SY; Polak ME; Theaker J; MacLeod AS; French RR; Glennie MJ; Al-Shamkhani A; Healy E
    Clin Cancer Res; 2016 Aug; 22(16):4236-48. PubMed ID: 27034329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MondoA-Thioredoxin-Interacting Protein Axis Maintains Regulatory T-Cell Identity and Function in Colorectal Cancer Microenvironment.
    Lu Y; Li Y; Liu Q; Tian N; Du P; Zhu F; Han Y; Liu X; Liu X; Peng X; Wang X; Wu Y; Tong L; Li Y; Zhu Y; Wu L; Zhang P; Xu Y; Chen H; Li B; Tong X
    Gastroenterology; 2021 Aug; 161(2):575-591.e16. PubMed ID: 33901495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid.
    Watson MJ; Vignali PDA; Mullett SJ; Overacre-Delgoffe AE; Peralta RM; Grebinoski S; Menk AV; Rittenhouse NL; DePeaux K; Whetstone RD; Vignali DAA; Hand TW; Poholek AC; Morrison BM; Rothstein JD; Wendell SG; Delgoffe GM
    Nature; 2021 Mar; 591(7851):645-651. PubMed ID: 33589820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T Regulatory Cells and Priming the Suppressive Tumor Microenvironment.
    Paluskievicz CM; Cao X; Abdi R; Zheng P; Liu Y; Bromberg JS
    Front Immunol; 2019; 10():2453. PubMed ID: 31681327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lineage Reprogramming of Effector Regulatory T Cells in Cancer.
    Dixon ML; Leavenworth JD; Leavenworth JW
    Front Immunol; 2021; 12():717421. PubMed ID: 34394124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly immunosuppressive HLADR
    Yang H; Ye S; Goswami S; Li T; Wu J; Cao C; Ma J; Lu B; Pei X; Chen Y; Yu J; Xu H; Qiu L; Afridi S; Xiang L; Zhang X
    Int J Cancer; 2020 Apr; 146(7):1993-2006. PubMed ID: 31709528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased frequency of Foxp3+ regulatory T cells in mice with hepatocellular carcinoma.
    Du Y; Chen X; Huang ZM; Ye XH; Niu Q
    Asian Pac J Cancer Prev; 2012; 13(8):3815-9. PubMed ID: 23098476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.
    Muroyama Y; Nirschl TR; Kochel CM; Lopez-Bujanda Z; Theodros D; Mao W; Carrera-Haro MA; Ghasemzadeh A; Marciscano AE; Velarde E; Tam AJ; Thoburn CJ; Uddin M; Meeker AK; Anders RA; Pardoll DM; Drake CG
    Cancer Immunol Res; 2017 Nov; 5(11):992-1004. PubMed ID: 28970196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control.
    Sanseviero E; O'Brien EM; Karras JR; Shabaneh TB; Aksoy BA; Xu W; Zheng C; Yin X; Xu X; Karakousis GC; Amaravadi RK; Nam B; Turk MJ; Hammerbacher J; Rubinstein MP; Schuchter LM; Mitchell TC; Liu Q; Stone EL
    Cancer Immunol Res; 2019 Aug; 7(8):1371-1380. PubMed ID: 31239316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment.
    Sasidharan Nair V; Saleh R; Toor SM; Cyprian FS; Elkord E
    Cancer Immunol Immunother; 2021 Aug; 70(8):2103-2121. PubMed ID: 33532902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
    Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
    Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell subsets and colorectal cancer: discerning the good from the bad.
    Scurr M; Gallimore A; Godkin A
    Cell Immunol; 2012 Sep; 279(1):21-4. PubMed ID: 23041206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4
    Alrasheed N; Lee L; Ghorani E; Henry JY; Conde L; Chin M; Galas-Filipowicz D; Furness AJS; Chavda SJ; Richards H; De-Silva D; Cohen OC; Patel D; Brooks A; Rodriguez-Justo M; Pule M; Herrero J; Quezada SA; Yong KL
    Clin Cancer Res; 2020 Jul; 26(13):3443-3454. PubMed ID: 32220887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity.
    Nakagawa H; Sido JM; Reyes EE; Kiers V; Cantor H; Kim HJ
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6248-53. PubMed ID: 27185917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.